SAM #75N98026Q00600

NIH Procurement of Illumina Infinium Methylation Screening Array-48 Kits for DNA Methylation Research

The National Institutes of Health (NIH), Office of the Director, Office of Logistics and Acquisition Operations, is seeking to procure specialized DNA methylation analysis kits for cardiovascular disease research. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Logistics and Acquisition Operations - Supporting the NIA Laboratory of Neurogenetics and the NHLBI Division of Intramural Research, Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO) - OEM Highlight: - Illumina, Inc. is the sole manufacturer and source of the Infinium Methylation Screening Array-48 Kits - No third-party intermediaries are authorized to supply these kits - Products Requested: - 20 units of Infinium Methylation Screening Array-48 Kits (Catalog No. 20112611) - Each kit includes a 48-sample BeadChip and all required reagents for the EX Methylation Assay after bisulfite conversion - Kits interrogate approximately 270,000 CpG methylation sites, including 123,776 new sites, and require 50 ng genomic DNA input per sample - Unique/Notable Requirements: - Kits must be compatible with existing Illumina iScan System and Infinium Automated Pipetting System with ILASS at the NIA Laboratory of Neurogenetics - Brand-name, non-competitive procurement due to proprietary technology and compatibility needs - Delivery required as soon as possible after award, but no later than the end of the specified period - Purpose: - Kits will be used for epigenome-wide association studies of DNA methylation patterns related to cardiovascular disease mortality risk

Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q00600. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (brand-name).This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122 for twenty (20) Infinium Methylation Screening Array-48 Kits (Catalog No. 20112611) in support of the NHLBI Division of Intramural Research, Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO). Illumina is the sole manufacturer and source of the Infinium Methylation Screening Array, a proprietary BeadChip product protected by patents and trade secrets, and the only methylation array compatible with the Illumina iScan System and Infinium Automated Pipetting System with ILASS already installed at the NIA Laboratory of Neurogenetics where the assays will be performed. No other manufacturer produces a functionally equivalent product, and Illumina has certified in writing that it has not authorized any third-party intermediary to provide the Illumina products required for this transaction (Quotation No. 4791799).(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026.(iv) The associated NAICS code is 325413 ¿ In-Vitro Diagnostic Substance Manufacturing, and the small business size standard is 1,250 employees. This requirement is not set aside for small business.

View original listing